MAPT and Alzheimer disease: Thus, the National Institute on Aging and the Alzheimer's Association proposed new diagnostic criteria for Alzheimer's disease in 2018, emphasizing the combination of tau and amyloid PET scans and the analysis of amyloid-β and tau proteins in CSF with clinical assessments [43, 44].